A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence
Abstract Background Early treatment of patients at risk for developing aggressive prostate cancer is able to delay metastasis and reduce mortality; as such, up-front identification of these patients is critical. Several risk classification systems, including CAPRA-S, are currently used for disease p...
Main Authors: | Shivani Kamdar, Neil E. Fleshner, Bharati Bapat |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07438-4 |
Similar Items
-
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
by: Shivani Kamdar, et al.
Published: (2019-03-01) -
Harnessing efficient multiplex PCR methods to detect the expanding Tet(X) family of tigecycline resistance genes
by: Kai Ji, et al.
Published: (2020-01-01) -
Estudo da expressão dos genes TETs e níveis de hidroximetilação em meduloblastoma
by: Karina Bezerra Salomão
Published: (2017) -
Estudo da expressão dos genes TETs e níveis de hidroximetilação em meduloblastoma
by: Salomão, Karina Bezerra
Published: (2017) -
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL
by: Candace J. Poole, et al.
Published: (2019-07-01)